MK-0431-179

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0431-179, covering 2010-08-03 to 2010-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) [Phase 1]